Cite
Cancer Cell Lysate Entrapment in CaCO3 Engineered with Polymeric TLR-Agonists: Immune-Modulating Microparticles in View of Personalized Antitumor Vaccination.
MLA
Lybaert, Lien, et al. “Cancer Cell Lysate Entrapment in CaCO3 Engineered with Polymeric TLR-Agonists: Immune-Modulating Microparticles in View of Personalized Antitumor Vaccination.” Chemistry of Materials, vol. 29, no. 10, May 2017, pp. 4209–17. EBSCOhost, https://doi.org/10.1021/acs.chemmater.6b05062.
APA
Lybaert, L., Keun Ah Ryu, Nuhn, L., De Rycke, R., De Wever, O., Chon, A. C., Esser-Kahn, A. P., & De Geest, B. G. (2017). Cancer Cell Lysate Entrapment in CaCO3 Engineered with Polymeric TLR-Agonists: Immune-Modulating Microparticles in View of Personalized Antitumor Vaccination. Chemistry of Materials, 29(10), 4209–4217. https://doi.org/10.1021/acs.chemmater.6b05062
Chicago
Lybaert, Lien, Keun Ah Ryu, Lutz Nuhn, Riet De Rycke, Olivier De Wever, Alfred C. Chon, Aaron P. Esser-Kahn, and Bruno G. De Geest. 2017. “Cancer Cell Lysate Entrapment in CaCO3 Engineered with Polymeric TLR-Agonists: Immune-Modulating Microparticles in View of Personalized Antitumor Vaccination.” Chemistry of Materials 29 (10): 4209–17. doi:10.1021/acs.chemmater.6b05062.